Clinical Trial

Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is an open-label trial evaluating feasibility, tolerability, safety and efficacy of psilocybin assisted cognitive processing therapy for chronic Posttraumatic Stress Disorder (PTSD).
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-27
Trial Details
NCT Number NCT06386003
Lead Sponsor Unity Health Toronto
Collaborators: Toronto Metropolitan University, University of Ottawa
Conditions Post Traumatic Stress Disorder, PTSD, Chronic PTSD
Enrollment 15 participants
Start Date 2026-06
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-26